Uta Engling Poulsen

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

Merete Lund Hetland, Ib Jarle Christensen, Ulrik Tarp et al. · Arthritis & Rheumatism · 2009 · 541 citations

Medicine, Internal Medicine, Pharmacotherapy +14

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry

Lene Dreyer, Lene Mellemkjær, Anne Rødgaard Andersen et al. · Annals of the Rheumatic Diseases · 2012 · 181 citations · Full text

Medicine, Oncology, Pharmacology +12

Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry

Else Helene Ibfelt, Jan Sørensen, Dorte Vendelbo Jensen et al. · Clinical Epidemiology · 2017 · 93 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry

Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Pernille Bøyesen et al. · Annals of the Rheumatic Diseases · 2012 · 30 citations

Medicine, Pharmacotherapy, Radiology +15

Which Factors Influence Radiographic Progression During Treatment with Tumor Necrosis Factor Inhibitors in Clinical Practice? Results from 930 Patients with Rheumatoid Arthritis in the Nationwide Danish DANBIO Registry

Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Pernille Bøyesen et al. · The Journal of Rheumatology · 2014 · 15 citations · Full text

Medicine, Pharmacotherapy, Immunopathology +15